"TOKYO (AFP) -- Israel's Teva Pharmaceutical Industries has decided to buy Japan's third-largest generic drug company Taiyo Pharmaceutical Industry for about $500 million, the Nikkei newspaper said Tuesday.
Teva, the world's top generic drug maker, will likely take control of Taiyo by purchasing a majority stake from the founding family and other shareholders, it said.
Teva started a Japanese unit in 2005 and formed a generic drug joint venture, Teva-Kowa Pharma, with midtier Japanese pharmaceutical firm Kowa in 2008."
Teva, the world's top generic drug maker, will likely take control of Taiyo by purchasing a majority stake from the founding family and other shareholders, it said.
Teva started a Japanese unit in 2005 and formed a generic drug joint venture, Teva-Kowa Pharma, with midtier Japanese pharmaceutical firm Kowa in 2008."
Read more
No comments:
Post a Comment